Profile: NovaRx Corporation is a clinical stage biopharmaceutical company that develops and delivers cell-based therapeutic vaccines for the treatment of cancer. Our Lucanix® is a whole cell-based vaccine comprised of four allogeneic cell lines gene-modified to block the secretion of TGF-β. We offer Glionix™ vaccine that consists of glioma cell lines in which TGF-β immunosuppression has been blocked.